[144] Hims & Hers Health, Inc. SEC Filing

Rhea-AI Filing Summary

Form 144 notice for Hims & Hers Health, Inc. (HIMS) reports a proposed sale of 8,410 Class A shares through Fidelity Brokerage Services on the NYSE with an aggregate market value of $424,705.00 and an approximate sale date of 09/17/2025. The shares were acquired on 09/15/2025 upon restricted stock vesting and the consideration is listed as compensation. The filing also discloses a prior sale by Irene Becklund of 8,485 Class A shares on 06/17/2025 for gross proceeds of $506,978.75. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.

Positive

• Sale originates from restricted stock vesting, indicating the shares were granted as compensation rather than purchased with nontransparent consideration
• Brokered sale via Fidelity shows standard market process and use of an established brokerage channel

Negative

• Insider sales disclosed: prior sale of 8,485 shares for $506,978.75 may be noted by investors as insider liquidity
• Filing lacks context on company performance, so the transaction cannot be assessed against operational or financial trends

Insights

Securities Analyst

TL;DR Insider restricted stock vested and an insider-proposed sale totaling ~8.4k shares (~$425k); a prior ~8.5k-share sale occurred in June.

The filing documents a routine Form 144 sale tied to restricted stock vesting with proceeds labeled as compensation, indicating these shares derived from employee awards rather than open-market purchases. The proposed sale size (~$425k) and the prior sale (~$507k) are modest relative to large-cap market caps and appear procedural. No additional financial metrics or company performance details are provided, limiting assessment to transactional disclosure.

Corporate Governance Expert

TL;DR Transaction disclosure aligns with compliance obligations; vested restricted shares are being sold through a broker.

The notice states acquisition by restricted stock vesting and sale through Fidelity, which suggests compliance with Section 16/Rule 144 requirements. The representation that the seller lacks material nonpublic information is included. There is no indication of a trading plan adoption date or other governance actions in the filing, and no allegations or irregularities are evident from the disclosed tables.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	8410	424705.00	217641958	09/17/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A	09/15/2025	Restricted Stock Vesting	Issuer			8410	09/15/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Irene Becklund 2269 Chestnut Street #523 San Francisco CA 94123	Class A	06/17/2025	8485	506978.75

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Form 144 for HIMS disclose about the proposed sale?

The form discloses a proposed sale of 8,410 Class A shares via Fidelity on the NYSE with an aggregate market value of $424,705.00 and an approximate sale date of 09/17/2025.

How were the shares being sold acquired according to the filing?

The filing states the shares were acquired on 09/15/2025 through restricted stock vesting and the payment nature is listed as compensation.

Did the filer sell shares recently before this notice?

Yes. The filing shows that Irene Becklund sold 8,485 Class A shares on 06/17/2025 for gross proceeds of $506,978.75.

Through which broker will the proposed sale be executed?

The proposed sale is to be executed through Fidelity Brokerage Services LLC (address listed in the filing) on the NYSE.

Does the filing indicate any undisclosed material information?

The person for whose account the securities are to be sold represents by signature that they do not know of any material adverse information about the issuer that has not been publicly disclosed.